ClinicalTrials.Veeva

Menu

Supplementation of Probiotics and Fruit Fibre to Patients With Fatty Liver

R

Region Skane

Status

Terminated

Conditions

Fatty Liver

Treatments

Dietary Supplement: Probiotics and fruit fibre

Study type

Interventional

Funder types

Other

Identifiers

NCT01423630
2008/517

Details and patient eligibility

About

Probiotics and fruit fibre are given for 12 weeks to patients with fatty liver disease.

The hypothesis is that probiotic bacteria and fruit fibre affect the gut microbial composition in a positive manner. The improved ecological system is believed to contribute to improved liver health and thereby counteract fatty liver disease.

Enrollment

11 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • be able to participate in magnetic resonance imaging

Exclusion criteria

  • unable to understand oral and written information

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

11 participants in 1 patient group

Probiotics and fruit fibre
Experimental group
Description:
Probiotics and fruit fibre
Treatment:
Dietary Supplement: Probiotics and fruit fibre

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems